Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2021-09-17

EMA Withdrawn: Telmisartan Teva (telmisartan) — Teva B.V.

View source ↗

Summary

Telmisartan Teva has been withdrawn from the European market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan Teva (telmisartan)

Snippet

Status: Withdrawn. Therapeutic area: Hypertension. MAH: Teva B.V.. Decision date: 09/02/2021